Clinical trials
Stroke trials in Austria with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2014 | 4 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Recruiting | 3 |
| Terminated | 2 |
| Suspended | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Insel Gruppe AG, University Hospital Bern | 2 |
| Medical University Innsbruck | 2 |
| Medical University of Vienna | 2 |
| University Hospital Heidelberg | 2 |
| Burl Concepts, Inc. | 1 |
| Columbia University | 1 |
| IRCCS San Camillo, Venezia, Italy | 1 |
| Karl Landsteiner University of Health Sciences | 1 |
| Ludwig Boltzmann Institute for Arthritis and Rehabilitation | 1 |
| Neurologisches Rehabiliationszentrum Rosenhügel | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Stroke | 21 |
| Cerebral Hemorrhage | 3 |
| Atrial Fibrillation | 2 |
| Ischemic Attack, Transient | 2 |
| Ischemic Stroke | 2 |
| Atherosclerosis | 1 |
| Brain Infarction | 1 |
| Cerebral Infarction | 1 |
| Cerebrovascular Disorders | 1 |
| Deglutition Disorders | 1 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.